aTYR PHARMA INC (ATYR) Debt Components
- 2020-09-30: Convertible Notes Payable, CurrentUSD (m); Long-term Debt, Current MaturitiesUSD $3.06M; Long-term Debt, Excluding Current MaturitiesUSD (m).
- 2020-06-30: Convertible Notes Payable, CurrentUSD (m); Long-term Debt, Current MaturitiesUSD $4.98M; Long-term Debt, Excluding Current MaturitiesUSD (m).
- 2020-03-31: Convertible Notes Payable, CurrentUSD (m); Long-term Debt, Current MaturitiesUSD $6.87M; Long-term Debt, Excluding Current MaturitiesUSD (m).
- 2019-12-31: Convertible Notes Payable, CurrentUSD (m); Long-term Debt, Current MaturitiesUSD $8.74M; Long-term Debt, Excluding Current MaturitiesUSD (m).
aTYR PHARMA INC Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD |
|---|---|---|---|
| 2020-09-30 | (m) | $3.06M | (m) |
| 2020-06-30 | (m) | $4.98M | (m) |
| 2020-03-31 | (m) | $6.87M | (m) |
| 2019-12-31 | (m) | $8.74M | (m) |
| 2019-09-30 | (m) | $7.84M | $2.74M |
| 2019-06-30 | (m) | $7.82M | $4.60M |
| 2019-03-31 | (m) | $7.79M | $6.44M |
| 2018-12-31 | (m) | $7.77M | $8.26M |
| 2018-09-30 | (m) | $7.74M | $10.06M |
| 2018-06-30 | (m) | $7.72M | $11.85M |
| 2018-03-31 | (m) | $7.03M | $12.95M |
| 2017-12-31 | (m) | $5.01M | $14.72M |
| 2017-09-30 | (m) | $2.27M | $12.48M |
| 2017-06-30 | (m) | $2.79M | $11.79M |
| 2017-03-31 | (m) | $1.09M | $8.48M |
| 2016-12-31 | (m) | $339.00K | $9.20M |
| 2015-12-31 | (m) | $3.37M | $1.78M |
| 2015-03-31 | $2.00M | (m) | (m) |
| 2014-12-31 | $2.00M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |